Topical Medications Are Dominating The Overall Actinic Keratosis Treatment Market
The purpose of this strategic research study, titled "Actinic Keratosis Treatment Market – Growth, Future Prospects, and Competitive Analysis, 2018–2026," was carried out for industry investors, company executives, and industry participants, providing in-depth insights to assist in strategic decisions related to opportunities in the actinic keratosis treatment market. High prevalence of actinic keratosis and the subsequent risk of developing malignancies is a key driver assisting the growth of the global actinic keratosis market. The actinic keratosis treatment options consist of destructive treatments, photodynamic therapy, topical medication, and others. Destructive treatment holds the largest market share in the segment due to factors such as excellent clinical outcomes and enhanced patient compatibility.
Objective
- To provide market size for the global actinic keratosis market from 2016 to 2018 (US$ Mn)
- To forecast global actinic keratosis market size from 2019 to 2026 (US$ Mn)
- To provide the above data for market segments such as treatments and geography
- To provide epidemiology forecasts of the actinic keratosis market from 2018 to 2026
- To understand prescription patterns associated with actinic keratosis
- To analyze why there is a lucrative future for topical treatment without local skin reaction
Market Scope
The market scope comprises broad segmentation on the basis of treatments and geography. Treatments considered include destructive treatments (liquid nitrogen cryotherapy, surgical therapy), photodynamic therapy (5-aminolevulinic acid, methyl aminolevulinate), chemical peeling and dermabrasion, and topical medications (5-fluorouracil, imiquimod, ingenol mebutate, diclofenac sodium). Geographic segmentation covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, sub-segmented into key countries.
Secondary Research
The study was initiated with in-depth and extensive secondary research drawing on company annual reports, press releases, scientific journals, university research papers, government websites, and paid databases including Factiva, Reuters, Hoovers, OneSource, and Bloomberg. Where public data was unavailable, modeling and estimates were used to arrive at comprehensive data sets, with pricing and prevalence data validated against stakeholder input and proprietary statistical models.
Primary Research
Secondary research was complemented by extensive primary research to validate data and analysis, including more than 250 respondent interviews globally (averaging 50 per region) via telephone, email, and face-to-face conversations with leading industry experts.
- Helps validate and strengthen the secondary research findings.
- Provides first-hand information on market trends, growth trends, market size, and competitive landscape within the industry.